Newman; Roland A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Newman; Roland A..The latest application filed is for "treating autoimmune diseases with humanized anti-cd401 antibodies".

Company Profile

0.18.10

Newman; Roland A. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Expression and use of anti-CD20 Antibodies Grant 7,744,877 - Anderson , et al. June 29, 2	2010-06-29
Anti-CD20 antibodies Grant 7,422,739 - Anderson , et al. September 9, 2	2008-09-09
Expression and use of anti-CD20 antibodies Grant 7,381,560 - Anderson , et al. June 3, 2	2008-06-03
Treating autoimmune diseases with humanized anti-CD40L antibody Grant 7,122,187 - Black , et al. October 17, 2	2006-10-17
Treating autoimmune diseases with humanized anti-CD401 antibodies App 20060153837 - Black; Amelia ; et al.	2006-07-13
Treating allergic diseases with humanized anti-CD40L antibody Grant 7,074,406 - Black , et al. July 11, 2	2006-07-11
Humanized antibodies to human GP39, compositions, and therapeutic uses thereof App 20060147446 - Black; Amelia ; et al.	2006-07-06
Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell Lymphoma App 20050186205 - Anderson, Darrell R. ; et al.	2005-08-25
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 6,682,734 - Anderson , et al. January 27, 2	2004-01-27
Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody App 20030170233 - Black, Amelia ; et al.	2003-09-11
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20030147885 - Anderson, Darrell R. ; et al.	2003-08-07
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma App 20030095963 - Anderson, Darrell R. ; et al.	2003-05-22
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20030082172 - Anderson, Darrell R. ; et al.	2003-05-01
Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20030021781 - Anderson, Darrell R. ; et al.	2003-01-30
Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies Grant 6,506,383 - Black , et al. January 14, 2	2003-01-14
Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20020197255 - Anderson, Darrell R. ; et al.	2002-12-26
Recombinant antibodies for human therapy App 20020150580 - Newman, Roland A. ; et al.	2002-10-17
Methods of treating autoimmune diseases with gp39-specific antibodies Grant 6,440,418 - Black , et al. August 27, 2	2002-08-27
Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma Grant 6,399,061 - Anderson , et al. June 4, 2	2002-06-04
Humanized antibodies to human gp39, compositions containing thereof Grant 6,001,358 - Black , et al. December 14, 1	1999-12-14
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 5,843,439 - Anderson , et al. December 1, 1	1998-12-01
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 5,776,456 - Anderson , et al. July 7, 1	1998-07-07
Recombinant antibodies for human therapy Grant 5,756,096 - Newman , et al. May 26, 1	1998-05-26
Recombinant antibodies for human therapy Grant 5,750,105 - Newman , et al. May 12, 1	1998-05-12
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 5,736,137 - Anderson , et al. April 7, 1	1998-04-07
Recombinant antibodies for human therapy Grant 5,693,780 - Newman , et al. December 2, 1	1997-12-02
Recombinant antibodies for human therapy Grant 5,681,722 - Newman , et al. October 28, 1	1997-10-28
Recombinant antibodies for human therapy Grant 5,658,570 - Newman , et al. August 19, 1	1997-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.